Detalhe da pesquisa
1.
Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B.
Hepatol Res
; 54(3): 252-260, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897705
2.
Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus-related liver cirrhosis.
Hepatol Res
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38838066
3.
VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
Dig Dis Sci
; 69(3): 851-869, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244124
4.
Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment.
Int J Mol Sci
; 25(8)2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38673992
5.
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.
Int J Mol Sci
; 25(5)2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473925
6.
Efficacy of a dedicated plastic stent in endoscopic ultrasound-guided hepaticogastrostomy during the learning curve: cumulative multi-center experience.
Scand J Gastroenterol
; 58(3): 296-303, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073949
7.
Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID-19 severity in patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(11): 1047-1058, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37469098
8.
Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis.
Hepatol Res
; 53(8): 713-722, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37050844
9.
Protein-losing gastroenteropathy complicated with asymptomatic primary biliary cholangitis, refractory to immunosuppressant, and improved by Helicobacter pylori eradication: a case report.
BMC Gastroenterol
; 22(1): 101, 2022 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255813
10.
Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute-on-chronic liver failure development and prognosis in patients with liver cirrhosis.
Hepatol Res
; 52(4): 390-400, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34964539
11.
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
Int J Mol Sci
; 23(17)2022 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077228
12.
Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis.
J Cell Mol Med
; 25(8): 4001-4013, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609067
13.
Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling.
Genes Dev
; 27(15): 1706-17, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913923
14.
Association between Equol Production Status and Nonalcoholic Steatohepatitis.
Int J Mol Sci
; 22(21)2021 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769332
15.
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis.
Int J Mol Sci
; 22(13)2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203178
16.
Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.
Dig Dis
; 38(4): 329-334, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31655803
17.
Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single-center study.
Hepatol Res
; 50(9): 1101-1105, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558192
18.
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.
Hepatol Res
; 50(7): 840-852, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32346970
19.
Effect of furosemide on muscle cramps in patients with liver cirrhosis.
J Gastroenterol Hepatol
; 35(1): 76-81, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385352
20.
Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
Int J Mol Sci
; 21(20)2020 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33066548